Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Enrolling 17,604 adults aged 45 or older with established cardiovascular disease and a BMI of 27 or higher (without diabetes), SELECT showed that semaglutide 2.4 mg reduced the composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke by 20% over a mean follow-up of nearly 40 months
But before rolling up your sleeve, stop and ask, what else comes with it
Clinical trials revealed an average loss of 20.9% in body weight among participants on the highest dose
The pipeline reflects the industry's focus on three goals: longer dosing intervals (every two weeks instead of weekly), oral formulations (to avoid injections), and multi-receptor agonism (to push past the 15% to 17% weight loss ceiling of pure GLP-1 agonists)
Help them gain with a plan to give them the upper paw on their cute physique
